Entity

Colorectal Cancer

Cancer of the colon or rectum — among the most common cancers worldwide and a major focus of screening and drug development.

As of 8 Oct 2026Last evidence 8 Oct 2026

What is happening now

Integrated spatial and single-cell transcriptomics uncover IFI6⁺ regulatory T-cells and SPP1⁺ macrophages immunosuppressive niches in colorectal cancer.
Reported claim · first reported 6 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers
REVERCE II: A Phase II trial of regorafenib followed by anti-EGFR therapy versus reverse sequencing in refractory metastatic colorectal cancer.
Reported claim · first reported 3 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers
Abbott launches SimpleScreen CRC blood test in the US
Reported claim · first reported 2 Oct 2026 · 1 claim · best-carried claim: 1 separate publisher

All 3 events and claims involving Colorectal Cancer

What changed

Attention Colorectal Cancer has 191 mentions in tracked coverage: too few to measure a trend.
State Changes between snapshots: cannot measure, no state history is kept for Colorectal Cancer yet.
Claims No claim first reported since 7 Oct 2026.

How well we know this

1,717 documents · 389 publishers · 8% contain a typed assertion · last evidence 8 Oct 2026

Gap: assertion coverage 0.084: about 92% of mentions carry no typed assertion

In this snapshot’s daily coverage:

Reported alongside Colorectal Cancer

Names most often reported alongside it; bigger circles and heavier lines mean more shared documents. A dashed circle has no page of its own yet.

Immunotherapy · 261 shared documents
KRAS · 132 shared documents
ctDNA · 123 shared documents · no page of its own yet
AI · 102 shared documents
Braf · 85 shared documents
FDA · 70 shared documents · no page of its own yet
Egfr · 68 shared documents · no page of its own yet
MSI-H · 65 shared documents
Zhang · 62 shared documents
Lung Cancer · 54 shared documents · no page of its own yet

Colorectal Cancer has 191 mentions in tracked coverage. That is too few to measure a trend. Watch Colorectal Cancer to hear when coverage grows, or request deeper coverage of Colorectal Cancer.

For developers

This page is also an object: GET https://sigb.ai/api/v1/node/e/e65e9524bedac8b311cd8e6e returns the same record as sb.node.v1. Or call the get_entity MCP tool at https://sigb.ai/api/mcp with name colorectal cancer.

{
  "name": "colorectal cancer",
  "label": "Colorectal Cancer",
  "asOf": "2026-10-08",
  "mentions": 191,
  "outlets": 125,
  "domains": 10,
  "node": {
    "id": "sb:e/e65e9524bedac8b311cd8e6e",
    "schema": "sb.node.v1",
    "rest": "https://sigb.ai/api/v1/node/e/e65e9524bedac8b311cd8e6e",
    "knowledgeCutoff": "2026-10-08T23:32:17.032179+00:00",
    "snapshot": "this deploy's committed data files (commit not exposed in this runtime)"
  },
  "coverageTrend": "too few mentions to measure",
  "whereFrom": {
    "level": "counts",
    "label": "191 mentions across 10 domains",
    "children": [
      {
        "level": "reports",
        "label": "6 reports drawn on this page, each with its link",
        "children": {
          "count": 6,
          "unfold": "expand=+1"
        }
      },
      {
        "level": "domains",
        "label": "10 coverage domains",
        "children": {
          "count": 10,
          "unfold": "expand=+1"
        }
      },
      {
        "level": "not shown",
        "label": "The other 185 mentions",
        "edge": "counted daily from tracked coverage; single mentions are not listed one by one"
      }
    ]
  }
}

The figures on this page, as data. The tool returns the full entity record.

Events involving Colorectal Cancer

Most-reported first, then newest. Registered events come from the event record; reported events are groups of claims about one occurrence. Claims are grouped when they were first reported within 2 days of each other and either name at least 2 of the same people, places or things besides this one, or share at least 25% of their wording. Each claim keeps its own record.

Integrated spatial and single-cell transcriptomics uncover IFI6⁺ regulatory T-cells and SPP1⁺ macrophages immunosuppressive niches in colorectal cancer.
Reported claim · first reported 6 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers
single source
REVERCE II: A Phase II trial of regorafenib followed by anti-EGFR therapy versus reverse sequencing in refractory metastatic colorectal cancer.
Reported claim · first reported 3 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers
single source
Abbott launches SimpleScreen CRC blood test in the US
Reported claim · first reported 2 Oct 2026 · 1 claim · best-carried claim: 1 separate publisher
single source

Walk the record from Colorectal Cancer

Open where it comes from, follow a claim or a related name, and use the trail to come back. Every step says what it is, how it stands and when. Machines read the same record.